Directory → Hormones and their antagonists → Androgens, antiandrogena → Finast
This page is translated automatically with a help of Google Translate
FinastSee also FinasterideRoman nameFinastPharmacokineticsAfter intake of rapidly absorbed from the digestive tract, bioavailability is about 80% (does not depend on the meals). C_max plasma achieved in 1-2 hours after oral reception, tying the plasma protein is about 90%. Metabolised in the liver, appears in the form of metabolites in urine and Kalom.t_1/2 in patients over the age of 60 is 6900, in patients over 70 years of age can be prolonged until 8 pmFarmakodinamikaDecreases of prostate cancer increases the maximum speed of the outflow of urine and reduces symptoms of this giperplaziei; Reduces the risk of severe delays urine and the resulting likelihood surgery.Clinical pharmacologyDuration of therapy to evaluate its effectiveness should not be less than six months. Approximately 50% of patients disappearance of clinical symptoms occurred in the treatment for 12 months.IndicationsSafe giperplazia prostate gland.ContraindicationsHypersensitivity, obstructive uropatia, child.Side-EffectsAllergic reactions ginekomastia, impotence, reduced libido, a decrease of volume (frequency of side effects does not exceed 3-4% and declined treatment). In some cases, there had been an improvement in the LTG, and opened testosterone approximately 10% (but they remained within normal limits).Specific guidanceA high volume of residual urine and / or sharply reduced current urine should be aware of obstructive uropathy.PrecautionsPrior to the start of treatment should be deleted disease simulirute good giperplaziu prostate cancer (prostate infection, cancer prostate, the urethra strictora, gipotoniceski bladder and changes from the mochevforodaschei system associated with certain diseases nervous system). Be wary appoint patients violations of the Pecheni.periodiceski in therapy it is necessary to examine patients to exclude their prostate cancer (as in the application finasterida there has been a decline �ростат-специфическог о antigen-by 41 and 48%, respectively, by 6 and 12 months since the start of therapy). Women of childbearing age and pregnant women should avoid contact with the tablets crashed preparation, in view of the development of the genital organs of embryos male.Storage conditionsList B. In a dry, the dark place at a temperature of no higher than 25 ° CShelf life2The registration014580/01-2002The drug formsWhite round dvoyakovpuklae pills Film-coated with the Rx symbol on one side and smooth on the other hand; An Matochkin-white, or almost white mass. |
All products of this group |

